Walleye Capital’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,691
Closed -$51.1K 4634
2024
Q4
$51.1K Buy
+20,691
New +$39.8K ﹤0.01% 4351
2022
Q1
Sell
-530,432
Closed -$2.52M 2417
2021
Q4
$2.52M Buy
+530,432
New +$2.13M 0.08% 273
2020
Q2
Sell
-27,380
Closed -$104K 787
2020
Q1
$104K Buy
+27,380
New +$101K 0.02% 589

Other funds holding IFRX

Walleye Capital's IFRX Position: Q1 2025 in Review

Walleye Capital sold out of InflaRx (IFRX) in Q1 2025, closing a stake of 20,691 shares — an estimated $51.1K sold.

Walleye Capital first reported a position in IFRX in Q1 2020 and held it in 3 quarters. The position peaked at $2.52M in Q4 2021. 31 funds tracked by Wall St. Rank hold IFRX as of Q1 2025.

  • Walleye Capital reported no remaining InflaRx position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 20,691 InflaRx shares in Q1 2025, an estimated $51.1K.
  • Walleye Capital first reported a position in InflaRx in Q1 2020 and held it in 3 quarters.
  • Walleye Capital's InflaRx position peaked at $2.52M in Q4 2021.
  • 31 funds tracked by Wall St. Rank held InflaRx as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.